Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

Affiliations

• ¹ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ² National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece.
• ³ University of Glasgow, Glasgow, UK.
• ⁴ Bayer, Research & Development, Pharmaceuticals, Berlin, Germany.
• ⁵ National Heart Centre Singapore & Duke-National University of Singapore, Singapore, Singapore.
• ⁶ University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy.
• ⁷ Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
• ⁸ University of Groningen, Groningen, The Netherlands.
• ⁹ University of Lorraine, Nancy, France.
• ¹⁰ Steno Diabetes Center Copenhagen and University of Copenhagen, Copenhagen, Denmark.
• ¹¹ Hospital 12 de Octubre, Madrid, Spain.
• ¹² Charité University, Berlin, Germany.
• ¹³ University of Michigan, Ann Arbor, MI, USA.
• ¹⁴ Indiana University School of Medicine, Indianapolis, IN, USA.
• ¹⁵ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. [email protected].